The objectives of the current study were to determine the anti CVB IgG/IgM antibody titers in the plasma of pregnant women during pregnancy using by clinical-grade serology assays, to determine the presence of viral nucleic acid in plasma and peripheral blood lymphocytes using ViroCap, and to assess the association between CVB burden and CHD outcomes. Here, CD40LG is linked to coronary artery disorder.